Questionnaire

1. Physiological changes that occur when observing the Ramadan fast might place people with acute or chronic illness at extreme risk for diverse complications, and they are therefore exempted from fasting.

2. Among medical and religious recommendations for PLWD and at moderate risk for fasting during Ramadan are that:

3. Changes in glycaemic control of patients with T2DM during the Ramadan fast  that have been demonstrated by CGM studies include:

4. For the patient with T2DM, dietary approaches that have demonstrated better glycaemic control during the Ramadan fast include:

5. Circumstances under which a patient with T2DM should break the fast include:

6. During Ramadan fasting, frequency of SMBG for all patients with T2DM should be:

7. Human insulins are preferred over insulin analogues for the management of T2DM during Ramadan due to their lower risk for hypoglycaemia and better postprandial glucose control.

8. Patients with T2DM and observing the fast should adjust their once-daily basal insulin dose by:

9. During Ramadan fasting, adjustments to bolus insulin regimens include:

10. Non-insulin hypoglycaemic medications that require adjustment to treatment regimen when observing the fast include: